Elizabeth S. Dodds Ashley, PharmD, MHS, FCCP, BCPS

Associate Director of Clinical Pharmacy Service
Adjunct Associate Professor of Pharmacy Practice
PGY-1 and PGY-2, Infectious Disease

Education: PharmD, Bouvé College of Pharmacy and Health Sciences, Northeastern University, 1998; MS in Clinical Research, Duke University School of Medicine, 2006.

Residency Training: ASHP Accredited Pharmacy Practice Residency, Duke University Health System, 1999.

Certification: Board Certified Pharmacotherapy Specialist, 1999 to present.

Faculty Appointments: Adjunct Associate Professor of Pharmacy Practice, University of Rochester Medical Center; Adjunct Assistant Professor, Department of Medicine, Division of Infectious Diseases and International Health, Duke University.

Professional Affiliations: American College of Clinical Pharmacy; Society of Infectious Disease Pharmacists; Triangle College of Clinical Pharmacy.

Practice Area: Infectious Diseases http://www.urmc.rochester.edu/medicine/infectious-disease

Publications: ES, Oberg KC. Erythematous bullous lesions on dorsum of hands due to contact exposure to ibutilide fumarate for injection. Pharmacotherapy 1998;18(4)880-82.Dodds ES, Oberg, KC. Does the intervention of identifying homeless clients who should receive lipid altering therapy decrease the incidence of cardiovascular events? Journal of Pharmacy Practice 1999;12:166-69; Dodds ES, Drew RH, Perfect JP. Applying principles of antifungal pharmacodynamics to the treatment of invasive fungal infections. Pharmacotherapy 2000;20:1335-55; Dodds ES, May DB, Drew RH. Vaccine update: Recent guideline changes and target population initiatives. North Carolina Medical Journal 2000;61:326-29; Dodds ES, Murray JD, Trexler KM, Grant JD. Metabolic occurrences in TPN patients managed by a NSS. Nutrition in Clinical Practice. 2001;16:78-84; Dodds ES, Drew RH, May DB, Washam JB, Gouviea-Pisano JA, Fulton KB, Luna B. Impact of a pharmacy student-based inpatient pneumococcal vaccination program. American Journal of Pharmaceutical Education 2001;65:258-60; Lu I, Dodds E, Perfect J. New antifungal agents. Seminars in Respiratory Infections 2002;17:140-50; Dodds Ashley ES, Kirk K, Fowler, VG. Patient detection of a drug dispensing error by use of physician-provided drug samples. Pharmacotherapy 2002;22:1642-3; Gallagher JC, Dodds Ashley ES, Drew RH, Perfect JR. Antifungal pharmacotherapy for invasive mould infections. Current Opinion in Pharmacotherapy 2003;4:147-64; Drew RH, Ashley ED, Benjamin DK, Davis RD, Palmer SM, Perfect JR. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung transplant recipients. Transplantation 2004;77:232-7; Alexander Lodge Dodds Ashley ES, Steele MP and Perfect JR. Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patients successfully treated with posaconazole. J. Clin Microbiol 2004;42:1376-78; Gallagher JC, MacDougall C, Dodds Ashley ES, Perfect JR. Recent Advances in antifungal therapy for invasive fungal infections. Expert Rev Anti-Infect Ther 2004;2:253-68; Dodds Ashley ES, Carroll DN, Engemann, JJ, Harris AD, Fowler, Jr. VG, Sexton, DJ, Kaye, KS Risk factors for post-operative mediastinitis due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004;38:1555-60; Perfect JR, Dodds Ashley ES, Drew RH. Design of aerosolized amphotericin B formulations for prophylaxis trials among lung transplant recipients. Clin Infect Dis 2004;39:S207-10; Dodds Ashley ES, Alexander BD. Posaconazole. Drugs of Today 2005;41:393-400; Alexander BD, Dodds Ashley ES, Addison RM, Alspaugh JA, Chao NJ, Perfect JR. Open-labeled, non-comparative evaluation of the safety and tolerability of aerosolized Amphotericin B lipid complex in patients undergoing allogeneic hematopoetic stem cell transplantation. Transplant Infect Dis 2006;8:13-20; Hickey AJ, Lu D, Ashley ED, Stout J. Inhaled azithromycin therapy. J Aerosol Med 2006;19:54-60; Alexander BD, Dodds Ashley ES, Reller LB, Reed SD. Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures. Diagnostic Microbiology and Infectious Diseases 2006;54:277-82; Dodds Ashley E. Treatment options for invasive fungal infections. Pharmacotherapy 2006;26:55S-60S; Kaye KS, Kanafani ZA, Dodds Ashley E, Engemann JJ, Weber SG, Carmeli Y. Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemother 2006;50:2192-96; Dodds Ashley ES, Lewis R, Lewis JS, Martin C, Andes D. Pharmacology of systemic antifungal agents. Clin Infect Dis 2006;43:S28-39; Zaas AK, Dodds Ashley ES, Alexander BD, Johnson MD, Perfect JR. Caspofungin use and outcome for invasive candidiasis at a tertiary care medical center. The American Journal of Medicine 2006;119:993e1-993e6; Dodds Ashley ES, Zaas AK, Fang AF, Damle B, Perfect JR. Comparative Pharmacokinetics of Voriconazole Administered Orally as either Crushed or Whole Tablets. Antimicrob Agents Chemother 2007;51:877-80; Bennett KM, Scarborough JE, Sharpe M, Dodds-Ashley E, Kaye KS, Hayward TZ, Vaslef SN. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. J Trauma 2007;63:307-11; Shi S, Dodds Ashley ES, Alexander BD, Hickey AJ. Initial Characterization of micafungin pulmonary delivery via two different nebulizers and multivariate data analysis of aerosol mass distribution profiles. AAPS PharmSciTech 2009;10:129-37; Connelly SM, Trinh JV, Johnson MD, Dodds Ashley ES, Stout J, Engemann JJ, Friedman ND, Kaye D, Kaye KS. Mortality and time to extubation in severe hospital-acquired pneumonia. American Journal of Infection Control 2009;37:143-9; Dodds Ashley ES, Varkey JB, Krishna G, Vickery D, Ma L, Yu X, Malavade D, Goodwin M, Perfect JR, Power E. Pharmacokinetics of posaconazole administered orally or by nasogastric tube in healthy volunteers. Antimicrob Agents Chemother 2009;53:2960-4; Le J, Dodds Ashley E, Neuhauser MM et al. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Pharmacotherapy 2010;30:562-84; Dodds Ashley E. Management of drug and food interactions with azole antifungal agents in transplant recipients. Pharmacotherapy 2010;30:842-54; Venuto C, Baker ML, Dodds Ashley ES, Brown JL. Alternative therapies for Clostridium difficile infections. Pharmacotherapy 2010;30:1266-78; Alexander B, Winkler T, Shuai S, Dodds Ashley E, Hickey T. Nebulizer delivery of micafungin aerosols. Pharmacotherapy 2011;31:52-7; Ohl CA and Dodds Ashley E. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis 2011;53:S23-8; Dodds Ashley ES Pharmacoeconomics of antifungal therapy: current considerations. Current Opinion in Infectious Disease 2011;24:S30-40.

Awards & Honors: American College of Clinical Pharmacy; Clinical Practitioner of the Year - New York State ACCP; Campbell University Preceptor of the Year; Duke University Pharmacy Practice Residency Preceptor of the Year;

Email: elizabeth_doddsashley@urmc.rochester.edu